편두통 치료 기기 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 설치 장소별, 제품 유형별, 치료법별, 유통 채널별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Migraine Treatment Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Site, By Product Type, By Therapy, By Distribution Channel, By End User, By Region and Competition, 2020-2030F
상품코드:1878819
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 편두통 치료 기기 시장은 2024년에 7억 4,964만 달러로 평가되었으며, 2030년까지 CAGR 8.54%로 성장하여 12억 2,572만 달러에 달할 것으로 예측됩니다.
전 세계 편두통 치료 기기 시장은 주로 신경자극요법 등 비약물 요법을 통해 편두통을 완화하거나 예방하기 위한 전문 의료기기를 포괄하고 있습니다. 이 시장의 주요 촉진요인은 효과적인 관리 솔루션을 필요로 하는 편두통 질환의 전 세계 유병률 증가입니다.
The Global Migraine Treatment Devices Market, valued at USD 749.64 Million in 2024, is projected to experience a CAGR of 8.54% to reach USD 1225.72 Million by 2030. The Global Migraine Treatment Devices Market encompasses specialized medical instruments designed to alleviate or prevent migraine headaches, primarily employing non-pharmacological approaches such as neurostimulation. A key driver for this market is the increasing global prevalence of migraine disorders, necessitating effective management solutions.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 749.64 Million
Market Size 2030
USD 1225.72 Million
CAGR 2025-2030
8.54%
Fastest Growing Segment
Homecare
Largest Market
North America
Key Market Drivers
The increasing global migraine prevalence constitutes a primary driver for the migraine treatment devices market, generating a substantial and expanding patient demographic in need of effective therapeutic options. Migraine, a debilitating neurological disorder, profoundly impacts quality of life and productivity, prompting individuals to seek diverse management solutions. The rising incidence globally underscores an urgent demand for innovative and accessible treatments, including non-pharmacological device-based therapies. According to 'The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region' published in Pain Ther. , December 2024, the global prevalence of migraine reached 1.16 billion cases in 2021, illustrating the immense number of individuals affected. This extensive burden necessitates the adoption of varied treatment modalities, fueling the market for specialized devices.
Key Market Challenges
A significant challenge impeding the growth of the Global Migraine Treatment Devices Market is the limited reimbursement coverage for these specialized instruments in various regions. This directly impacts market expansion by restricting patient access and hindering affordability. When innovative non-pharmacological migraine therapies, such as neurostimulation devices, lack comprehensive insurance coverage, patients often face substantial out-of-pocket costs. This financial burden can deter individuals from adopting these treatments, even when clinically appropriate.
Key Market Trends
The Global Migraine Treatment Devices Market is being significantly shaped by two distinct, influential trends. The first involves a growing patient preference for non-invasive devices. Patients increasingly seek therapeutic options that circumvent the side effects and complexities often associated with pharmacological treatments. This shift fosters demand for user-friendly, non-pharmacological alternatives for migraine management. According to MedTech Europe, the European medical device market recorded a growth rate of 2.4% in 2023, reflecting a broader acceptance and integration of diverse medical devices, including non-invasive options, into patient care. This preference is further demonstrated by real-world data, where 64.2% of school-aged participants effectively managed their migraine symptoms using the Nerivio REN wearable, a discreet, non-drug treatment, as reported by Theranica in December 2024. This indicates a strong inclination towards devices that offer effective relief without medication.
Key Market Players
Theranica Bio-Electronics Ltd.
CEFALY Technology SPRL
ElectroCore, Inc.
eNeura Inc.
Neurolief Ltd.
Cirrus Healthcare Products LLC
Neuros Medical Inc.
Salvia BioElectronics B.V.
Theranica Bio-Electronics Ltd.
Dr Reddy's Laboratories Ltd.
Report Scope:
In this report, the Global Migraine Treatment Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Single Pulse Transcranial Magnetic Stimulator (sTMS)
gammaCore Non-Invasive Vagus Nerve Stimulator
Others
Migraine Treatment Devices Market, By Site:
Handheld
Headband
Others
Migraine Treatment Devices Market, By Product Type:
Prescription
Over The Counter
Migraine Treatment Devices Market, By Therapy:
Acute Therapy
Preventive Therapy
Migraine Treatment Devices Market, By Distribution Channel:
Hospital Based Pharmacies
Retail Pharmacies
Online Pharmacies
Migraine Treatment Devices Market, By End User:
Hospitals & Clinics
Homecare
Others
Migraine Treatment Devices Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Migraine Treatment Devices Market.
Available Customizations:
Global Migraine Treatment Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Migraine Treatment Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (External Trigeminal Nerve Stimulation (e-TNS) Device, Single Pulse Transcranial Magnetic Stimulator (sTMS), gammaCore Non-Invasive Vagus Nerve Stimulator, Others)
5.2.2. By Site (Handheld, Headband, Others)
5.2.3. By Product Type (Prescription, Over The Counter)
5.2.4. By Therapy (Acute Therapy, Preventive Therapy)
5.2.5. By Distribution Channel (Hospital Based Pharmacies, Retail Pharmacies, Online Pharmacies)
5.2.6. By End User (Hospitals & Clinics, Homecare, Others)
5.2.7. By Region
5.2.8. By Company (2024)
5.3. Market Map
6. North America Migraine Treatment Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Site
6.2.3. By Product Type
6.2.4. By Therapy
6.2.5. By Distribution Channel
6.2.6. By End User
6.2.7. By Country
6.3. North America: Country Analysis
6.3.1. United States Migraine Treatment Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Site
6.3.1.2.3. By Product Type
6.3.1.2.4. By Therapy
6.3.1.2.5. By Distribution Channel
6.3.1.2.6. By End User
6.3.2. Canada Migraine Treatment Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Site
6.3.2.2.3. By Product Type
6.3.2.2.4. By Therapy
6.3.2.2.5. By Distribution Channel
6.3.2.2.6. By End User
6.3.3. Mexico Migraine Treatment Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Site
6.3.3.2.3. By Product Type
6.3.3.2.4. By Therapy
6.3.3.2.5. By Distribution Channel
6.3.3.2.6. By End User
7. Europe Migraine Treatment Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Site
7.2.3. By Product Type
7.2.4. By Therapy
7.2.5. By Distribution Channel
7.2.6. By End User
7.2.7. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Migraine Treatment Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Site
7.3.1.2.3. By Product Type
7.3.1.2.4. By Therapy
7.3.1.2.5. By Distribution Channel
7.3.1.2.6. By End User
7.3.2. France Migraine Treatment Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Site
7.3.2.2.3. By Product Type
7.3.2.2.4. By Therapy
7.3.2.2.5. By Distribution Channel
7.3.2.2.6. By End User
7.3.3. United Kingdom Migraine Treatment Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Site
7.3.3.2.3. By Product Type
7.3.3.2.4. By Therapy
7.3.3.2.5. By Distribution Channel
7.3.3.2.6. By End User
7.3.4. Italy Migraine Treatment Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Site
7.3.4.2.3. By Product Type
7.3.4.2.4. By Therapy
7.3.4.2.5. By Distribution Channel
7.3.4.2.6. By End User
7.3.5. Spain Migraine Treatment Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Site
7.3.5.2.3. By Product Type
7.3.5.2.4. By Therapy
7.3.5.2.5. By Distribution Channel
7.3.5.2.6. By End User
8. Asia Pacific Migraine Treatment Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Site
8.2.3. By Product Type
8.2.4. By Therapy
8.2.5. By Distribution Channel
8.2.6. By End User
8.2.7. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Migraine Treatment Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Site
8.3.1.2.3. By Product Type
8.3.1.2.4. By Therapy
8.3.1.2.5. By Distribution Channel
8.3.1.2.6. By End User
8.3.2. India Migraine Treatment Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Site
8.3.2.2.3. By Product Type
8.3.2.2.4. By Therapy
8.3.2.2.5. By Distribution Channel
8.3.2.2.6. By End User
8.3.3. Japan Migraine Treatment Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Site
8.3.3.2.3. By Product Type
8.3.3.2.4. By Therapy
8.3.3.2.5. By Distribution Channel
8.3.3.2.6. By End User
8.3.4. South Korea Migraine Treatment Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Site
8.3.4.2.3. By Product Type
8.3.4.2.4. By Therapy
8.3.4.2.5. By Distribution Channel
8.3.4.2.6. By End User
8.3.5. Australia Migraine Treatment Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Site
8.3.5.2.3. By Product Type
8.3.5.2.4. By Therapy
8.3.5.2.5. By Distribution Channel
8.3.5.2.6. By End User
9. Middle East & Africa Migraine Treatment Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Site
9.2.3. By Product Type
9.2.4. By Therapy
9.2.5. By Distribution Channel
9.2.6. By End User
9.2.7. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Migraine Treatment Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Site
9.3.1.2.3. By Product Type
9.3.1.2.4. By Therapy
9.3.1.2.5. By Distribution Channel
9.3.1.2.6. By End User
9.3.2. UAE Migraine Treatment Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Site
9.3.2.2.3. By Product Type
9.3.2.2.4. By Therapy
9.3.2.2.5. By Distribution Channel
9.3.2.2.6. By End User
9.3.3. South Africa Migraine Treatment Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Site
9.3.3.2.3. By Product Type
9.3.3.2.4. By Therapy
9.3.3.2.5. By Distribution Channel
9.3.3.2.6. By End User
10. South America Migraine Treatment Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Site
10.2.3. By Product Type
10.2.4. By Therapy
10.2.5. By Distribution Channel
10.2.6. By End User
10.2.7. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Migraine Treatment Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Site
10.3.1.2.3. By Product Type
10.3.1.2.4. By Therapy
10.3.1.2.5. By Distribution Channel
10.3.1.2.6. By End User
10.3.2. Colombia Migraine Treatment Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Site
10.3.2.2.3. By Product Type
10.3.2.2.4. By Therapy
10.3.2.2.5. By Distribution Channel
10.3.2.2.6. By End User
10.3.3. Argentina Migraine Treatment Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Site
10.3.3.2.3. By Product Type
10.3.3.2.4. By Therapy
10.3.3.2.5. By Distribution Channel
10.3.3.2.6. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Migraine Treatment Devices Market: SWOT Analysis
